Croscarmellose Sodium
18 organisations hold 19 active FDA Type IV Drug Master Files for Croscarmellose Sodium. 1 further filing is inactive and shown as history. 2 valid EDQM Certificates of Suitability are on record for the same substance.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology
Active Type IV DMFs (19)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| JIANGXI ALPHA HI-TECH PHARMACEUTICAL CO LTD | 40809 | CROSCARMELLOSE SODIUM | Sept 2026 |
| J R DRUGCHEM PVT LTD | 40345 | CROSCARMELLOSE SODIUM IP/BP/USP | Aug 2024 |
| ANMOL CHEMICALS PRIVATE LTD | 39746 | CROSCARMELLOSE SODIUM BP/EP/USP | Mar 2024 |
| AMSTER MICROCELL PRIVATE LTD | 38142 | CROSCARMELLOSE SODIUM | Jun 2023 |
| GANGWAL HEALTHCARE PRIVATE LTD | 37534 | CROSCARMELLOSE SODIUM USP | Sept 2022 |
| SIGACHI INDUSTRIES LTD | 36537 | CROSCARMELLOSE SODIUM | Feb 2022 |
| ABHISHEK ORGANICS PVT LTD | 36718 | CROSCARMELLOSE SODIUM | Jan 2022 |
| KEVAL EXPORTS | 36002 | CROSCARMELLOSE SODIUM EP/BP/USP | Jun 2021 |
| ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO LTD | 35155 | CROSCARMELLOSE SODIUM | Sept 2020 |
| SILVERLINE CHEMICALS | 34457 | CROSCARMELLOSE SODIUM USP/BP/EP/IP/JP | Feb 2020 |
| MAPLE BIOTECH PVT LTD | 34494 | CROSCARMELLOSE SODIUM | Jan 2020 |
| PRACHIN PHARMACHEM PRIVATE LTD | 32704 | CROSCARMELLOSE SODIUM USP | Jul 2018 |
| CREST CELLULOSE PRIVATE LIMITED | 32790 | CROSCARMELLOSE SODIUM (CRESTCROSS) | Apr 2018 |
| Jrs Pharma Germany | 24951 | CROSCARMELLOSE SODIUM, PH.EUR., NF, JP | May 2011 |
| MINGTAI CHEMICAL CO LTD | 24910 | CROSCARMELLOSE SODIUM NF (PROCESS II) | Jan 2011 |
| RELIANCE CELLULOSE PRODUCTS LTD | 18875 | CROSCARMELLOSE SODIUM USP | Sept 2005 |
| NICHIRIN CHEMICAL INDUSTRIES LTD | 18242 | CROSCARMELLOSE SODIUM, NF | Mar 2005 |
| MINGTAI CHEMICAL CO LTD | 12787 | CROSCARMELLOSE SODIUM NF (PROCESS I) | Dec 1997 |
| DFE PHARMA GMBH AND CO KG Germany | 9662 | PRIMELLOSE (CROSCARMELLOSE SODIUM) | Apr 1992 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
Valid CEPs for this substance (2)
| Holder | Country | Certificate | Issued |
|---|---|---|---|
| Mingtai Chemical Co., Ltd. Taoyuan Hsien TW | TW | R1-CEP 2012-141 - Rev 00 Croscarmellose sodium, Process II | Sept 2019 |
| Mingtai Chemical Co., Ltd. Taoyuan Hsien TW | TW | R1-CEP 2002-250 - Rev 00 Croscarmellose sodium | Feb 2010 |
Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Inactive filings (1)
- BRAHMAR CELLULOSE PRODUCTS PRIVATE LTD · CROSCARMELLOSE SODIUM USP-NFDMF 22346 · Nov 2008
Inactive filings are closed or lapsed and cannot be referenced. They are shown as history only.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Croscarmellose Sodium.
Do you supply Croscarmellose Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.